EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways

Yelena Kravtsova-Ivantsiv, Gilad Goldhirsh iD, Aaron Ciechanover iD

Proceedings of the National Academy of Sciences · 24.12.2024 · 121 (52)

DOI: 10.1073/pnas.2416909121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 17.12.2024. Verfasst von Yelena Kravtsova-Ivantsiv und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Rappaport Faculty of Medicine and Research Institute, and the Rappaport Technion Integrated Cancer Center (R-TICC), Technion-Israel Institute of …. Hauptthemen laut MEDLINE: B7-H1 Antigen, Chemokine CXCL12, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Israel Science Foundation (ISF), Israel Personal Medicine Partnership - IPMP, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytokines constitute a family of proteins that modulate the immune system and are secreted by many cells. CXCL12, along with its receptor CXCR4, are essential players in numerous processes. Dysregulation of their function underlie the mechanism(s) of several pathologies, including malignancies. Here, we demonstrate an unexpected effect of the cytokine and its receptor: In both cells and animal models, CXCL12 restricts tumorigenicity of the human glioblastoma cells U87-MG and U-118, and of a cell line derived from PyMT mouse breast cancer. Overexpression of CXCL12 inhibits activation of the oncogene Ras which results in downregulation of its proliferative signals, such as reduced phosphorylation of the extracellular signal-regulated kinase 1/2 (ERK1/2), inhibition of c-Myc expression, and subsequent inhibition of cell cycle. Furthermore, CXCL12 induces downregulation of the growth differentiation factor 15 (GDF15), insulin-like growth factor-binding protein 6 (IGFBP6), and matrix metalloproteinase-3 (MMP3), which are implicated in sending metastases. Indeed, monitoring cell migration in vitro and generation of metastases in mice demonstrate that CXCL12 slows the migration of U87-MG and PyMT cells. Remarkably, overexpression of CXCL12 also downregulates the cell surface immune checkpoint protein programmed cell death-ligand 1 (PD-L1), resulting in recruitment of cytotoxic CD8 T cells into xenografts accompanied by their shrinkage. Overall, CXCL12 inhibits tumor growth through several distinct mechanisms: inhibition of cell cycle and migration, as well as impairment of immune checkpoint, thereby stimulating a strong host’s immune response. The mechanism(s) that renders CXCL12 a tumor-promoting factor in certain cells and a suppressor in others has remained elusive.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenChemokine CXCL12Proto-Oncogene Proteins c-mycAnimalsHumansMiceCell Line, Tumorras ProteinsCell ProliferationMAP Kinase Signaling SystemFemale

Stichwörter der Autor:innen

CXCL12protein degradationtumor suppressors

Substanzen

B7-H1 AntigenChemokine CXCL12Proto-Oncogene Proteins c-mycras ProteinsCXCL12 protein, humanCD274 protein, humanMYC protein, human

Autor:innen und Institutionen

  • The Rappaport Faculty of Medicine and Research Institute, and the Rappaport Technion Integrated Cancer Center (R-TICC), Technion-Israel Institute of Technology, Haifa 3109601, Israel.

ORCID-Profile: Gilad Goldhirsh, Aaron Ciechanover

Förderung

  • Israel Science Foundation (ISF)
  • Israel Personal Medicine Partnership - IPMP
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)
  • Israel Cancer Research Fund (ICRF)
  • ATS | Technion Fund, American Technion Society (ATS Technion)

Zitieren

APA

Kravtsova-Ivantsiv, Y., Goldhirsh, G., & Ciechanover, A. (2024). CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways. Proceedings of the National Academy of Sciences, 121(52). https://doi.org/10.1073/pnas.2416909121

Vancouver

Kravtsova-Ivantsiv Y, Goldhirsh G, Ciechanover A. CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways. Proceedings of the National Academy of Sciences. 2024;121(52). doi:10.1073/pnas.2416909121

BibTeX
@article{KravtsovaIvantsiv2024,
  author = {Kravtsova-Ivantsiv, Yelena and Goldhirsh, Gilad and Ciechanover, Aaron},
  title = {CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {52},
  doi = {10.1073/pnas.2416909121}
}
Kostenlos starten →